NYSE:TMO • US8835561023
The current stock price of TMO is 500.08 USD. Today TMO is down by -1.94%. In the past month the price decreased by -8.54%. In the past year, price decreased by -4.21%.
ChartMill assigns a technical rating of 0 / 10 to TMO. When comparing the yearly performance of all stocks, TMO is a bad performer in the overall market: 76.55% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to TMO. TMO has an average financial health and profitability rating.
On January 29, 2026 TMO reported an EPS of 6.57 and a revenue of 12.21B. The company beat EPS expectations (0.91% surprise) and beat revenue expectations (1.21% surprise).
33 analysts have analysed TMO and the average price target is 678.16 USD. This implies a price increase of 35.61% is expected in the next year compared to the current price of 500.08.
For the next year, analysts expect an EPS growth of 8.45% and a revenue growth 5.79% for TMO
Over the last trailing twelve months TMO reported a non-GAAP Earnings per Share(EPS) of 22.87. The EPS increased by 4.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.05% | ||
| ROA | 6.08% | ||
| ROE | 12.55% | ||
| Debt/Equity | 0.67 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| DHR | DANAHER CORP | 22.99 | 138.048B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.13 | 44.453B | ||
| A | AGILENT TECHNOLOGIES INC | 17.25 | 32.632B | ||
| WAT | WATERS CORP | 20.62 | 29.394B | ||
| IQV | IQVIA HOLDINGS INC | 13.34 | 28.694B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.26 | 25.041B | ||
| ILMN | ILLUMINA INC | 23.38 | 18.707B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 28.86 | 16.84B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.78 | 13.248B | ||
| RVTY | REVVITY INC | 16.38 | 10.096B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.099B | ||
| TECH | BIO-TECHNE CORP | 23.74 | 8.264B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.
IPO: 1980-08-27
THERMO FISHER SCIENTIFIC INC
168 Third Avenue
Waltham MASSACHUSETTS 02451 US
CEO: Marc N. Casper
Employees: 125000
Phone: 17816221000
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.
The current stock price of TMO is 500.08 USD. The price decreased by -1.94% in the last trading session.
THERMO FISHER SCIENTIFIC INC (TMO) has a dividend yield of 0.36%. The yearly dividend amount is currently 1.68.
TMO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
33 analysts have analysed TMO and the average price target is 678.16 USD. This implies a price increase of 35.61% is expected in the next year compared to the current price of 500.08.
The PE ratio for THERMO FISHER SCIENTIFIC INC (TMO) is 21.87. This is based on the reported non-GAAP earnings per share of 22.87 and the current share price of 500.08 USD.
THERMO FISHER SCIENTIFIC INC (TMO) will report earnings on 2026-04-21, before the market open.